Granisetron Hydrochloride Injection

It is a highly selective 5-HT3 receptor antagonist, which has a good preventive and therapeutic effect on nausea and vomiting caused by radiotherapy, chemotherapy and surgery. Factors such as radiotherapy, chemotherapy and surgery can cause enterochromaffin cells to release 5-HT, which can activate the 5-HT3 receptors of the central nervous system or vagus nerve and cause vomiting reflex. The mechanism of this product to control nausea and vomiting is to antagonize the 5-HT3 receptors in the central chemoreceptor area and peripheral vagus nerve endings, thereby inhibiting the occurrence of nausea and vomiting. This product has high selectivity and no adverse reactions such as extrapyramidal reactions and excessive sedation.

The main ingredient of this product is granisetron hydrochloride, and its chemical name is 1-methyl-N-(endo-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl)-1H-indazole-3-carboxamide hydrochloride.

Colorless or almost colorless clear liquid.

This product is used to prevent or treat nausea and vomiting caused by chemotherapy, and to prevent and treat postoperative nausea and vomiting

Intravenous injection: Adults: The dosage is usually 3 mg, diluted with 20-50 ml of 5% glucose injection or 0.9% sodium chloride injection, and injected intravenously 30 minutes before treatment. The administration time should exceed 5 minutes. Most patients only need to be given once, and the prevention effect on nausea and vomiting can exceed 24 hours. If necessary, the number of administrations can be increased by 1-2 times, but the maximum daily dose should not exceed 9 mg. Patients with liver and kidney dysfunction do not need to adjust the dose.

Common adverse reactions include headache, fatigue, fever, constipation, and occasional transient asymptomatic increase in liver aminotransferase. These reactions are mild and do not require special treatment.

1. Patients who are allergic to this product or related compounds are prohibited from using this product. 2. Patients with gastrointestinal obstruction are prohibited from using this product.

Not yet clear.

Keep away from light and store in a sealed container below 30℃.

1ml:1mg (based on granisetron)

Hainan Helpson MEDICINE & Biotechnique Co., Ltd.

• Founded in:

  1993-02-25

• Address:

  Haikou Free Trade Zone C09-2

• Tax NO.:

  9146000062000933XE

• Registered Funds:

  100 million yuan

• Website:

  Log in to view

• Email:

  Log in to view